ICD-10-CM | Description |
---|---|
C21.8 | Malignant neoplasm of overlapping sites of rectum, anus and anal canal |
2018/2019 ICD-10-CM Diagnosis Code C20. Malignant neoplasm of rectum. C20 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Malignant carcinoid tumor of the rectum 2016 2017 2018 2019 2020 2021 Billable/Specific Code C7A.026 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM C7A.026 became effective on October 1, 2020.
2021 ICD-10-CM Diagnosis Code C18.9 Malignant neoplasm of colon, unspecified 2016 2017 2018 2019 2020 2021 Billable/Specific Code C18.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Aftercare following surgery for neoplasm 1 Z48.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2020 edition of ICD-10-CM Z48.3 became effective on October 1, 2019. 3 This is the American ICD-10-CM version of Z48.3 - other international versions of ICD-10 Z48.3 may differ.
ICD-10 code Z92. 21 for Personal history of antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10 code C20 for Malignant neoplasm of rectum is a medical classification as listed by WHO under the range - Malignant neoplasms .
If the rectum is included with the colon cancer, then assign code 154.0, Malignant neoplasm of rectosigmoid junction. Metastasis to the colon or rectum is classified to code 197.5. Carcinoma of the colon is assigned to code 230.3 while carcinoma of the rectum goes to 230.4.
ICD-10-CM Code for Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus Z85. 048.
Code C80. 1, Malignant (primary) neoplasm, unspecified, equates to Cancer, unspecified.
C18. 9 - Malignant neoplasm of colon, unspecified. ICD-10-CM.
The colonoscopy or sigmoidoscopy is still classified as a preventive service eligible for coverage at the no-member-cost-share benefit level. a. Submit the claim with Z12. 11 (Encounter for screening for malignant neoplasm of colon) as the first-listed diagnosis code; this is the reason for the service or encounter.
C20: Malignant neoplasm of rectum.
Malignant neoplasm of colon, unspecified The 2022 edition of ICD-10-CM C18. 9 became effective on October 1, 2021.
Rectal cancer is a disease in which malignant (cancer) cells form in the tissues of the rectum. Health history affects the risk of developing rectal cancer. Signs of rectal cancer include a change in bowel habits or blood in the stool. Tests that examine the rectum and colon are used to diagnose rectal cancer.
ICD-10 code: K57. 92 Diverticulitis of intestine, part unspecified, without perforation, abscess or bleeding.
569.42 - Anal or rectal pain. ICD-10-CM.
Malignant neoplasm of colon. Approximate Synonyms. Cancer of the colon. Cancer of the colon, adenocarcinoma. Cancer of the colon, hereditary nonpolyposis. Cancer of the colon, stage 1. Cancer of the colon, stage 2. Cancer of the colon, stage 3. Cancer of the colon, stage 4.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
Malignant tumor of colon. Metastasis from malignant tumor of colon. Primary adenocarcinoma of colon. Clinical Information. A primary or metastatic malignant neoplasm involving the colon. A primary or metastatic malignant neoplasm that affects the colon or rectum.
For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Malignant neoplasm of ectopic tissue. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion '), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous such as tumors in different quadrants of the same breast, codes for each site should be assigned.
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms , such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm, it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary ( metastatic) sites should also be determined.
Code C80.0, Disseminated malignant neoplasm, unspecified, is for use only in those cases where the patient has advanced metastatic disease and no known primary or secondary sites are specified. It should not be used in place of assigning codes for the primary site and all known secondary sites.
When a pregnant woman has a malignant neoplasm, a code from subcategory O9A.1 -, malignant neoplasm complicating pregnancy, childbirth, and the puerperium, should be sequenced first, followed by the appropriate code from Chapter 2 to indicate the type of neoplasm. Encounter for complication associated with a neoplasm.
There are also codes Z85.6, Personal history of leukemia, and Z85.79, Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues. If the documentation is unclear as to whether the leukemia has achieved remission, the provider should be queried.
When an encounter is for a pathological fracture due to a neoplasm, and the focus of treatment is the fracture, a code from subcategory M84.5, Pathological fracture in neoplastic disease, should be sequenced first, followed by the code for the neoplasm.